Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q1 2025 Earnings

26FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.72

-0.54

-0.37

-0.19

Details

Expected EPS

-0.620269

Actual EPS

-0.72

Surprise EPS

-0.1

Surprise Percent

+16.08%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.72 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.